Oklahoma-based orthopedic surgeon Mark Stephen Wilson, M.D. and the United States have entered into an agreement resolving False Claims Act allegations.
Dr. Wilson primarily practices in Tulsa and Oklahoma City. He specializes in pain management and rehabilitation. In addition to Dr. Wilson, the allegations involved Brookhaven Specialty Pharmacy LLC, a pharmacy based in Norman, Oklahoma.
The U.S. Attorney’s Office for the Northern District of Oklahoma issued a press release on the matter. Per the press release, “[f]rom February 2014 through September 2016, [Dr.] Wilson was alleged to have knowingly accepted significant payments from Brookhaven Specialty Pharmacy LLC in exchange for recommending and prescribing pain creams that were compounded and produced by the pharmacy.”
During that time, Brookhaven Specialty Pharmacy allegedly paid Dr. Wilson “‘medical director fees’ based upon an hourly rate.” However, the United States contends that the “medical director fees” were not fees and instead were “kickback payments for prescribing the compounded pain creams.”
Dr. Wilson purportedly wrote prescriptions for the compounded pain creams for patients insured under the Federal Employees’ Compensation Act (FECA). Per its website, the FECA program “provides appropriate monetary and medical benefits to federal employees who have sustained work-related injuries or disease.”
As its name denotes, FECA is a federal program. Federal law prohibits physicians from receiving “kickbacks” when...
Image: Facebook/SAPS The IDAC has rubbished rumours that it has a J50 warrant of arrest for KZN provincial police commissioner Lieutenant-General Nhlanhla Mkhwanazi as “false”. This comes after re...